Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)

Aurisco Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,588	8,579	10,488	10,029	8,830	6,364
Market Cap Growth	47.29%	-18.20%	4.58%	13.58%	38.75%	-
Enterprise Value	12,538	8,317	10,056	9,726	8,296	5,718
Last Close Price	30.99	20.82	25.21	23.96	21.25	15.19
PE Ratio	29.15	24.18	36.24	47.54	52.34	40.48
Forward PE	27.67	18.69	30.47	39.82	-	-
PS Ratio	7.75	5.81	8.31	9.95	10.99	8.82
PB Ratio	4.95	3.68	5.33	5.96	5.86	4.59
P/TBV Ratio	5.28	3.95	5.68	6.46	6.02	4.74
P/FCF Ratio	324.03	-	130.89	-	-	114.29
P/OCF Ratio	32.92	25.81	27.20	60.27	43.81	29.67
EV/Sales Ratio	7.72	5.64	7.97	9.65	10.33	7.93
EV/EBITDA Ratio	21.62	17.78	28.49	35.61	35.42	25.54
EV/EBIT Ratio	25.72	21.53	36.07	46.71	45.40	29.80
EV/FCF Ratio	322.75	-	125.50	-	-	102.69
Debt / Equity Ratio	0.39	0.41	0.06	0.03	0.01	-
Debt / EBITDA Ratio	1.71	2.00	0.33	0.19	0.08	-
Debt / FCF Ratio	25.52	-	1.46	-	-	-
Asset Turnover	0.42	0.46	0.55	0.54	0.49	0.55
Inventory Turnover	1.10	1.15	1.18	1.28	1.45	1.60
Quick Ratio	2.98	2.68	1.69	1.92	3.06	5.02
Current Ratio	4.30	3.85	2.73	3.38	4.87	6.91
Return on Equity (ROE)	17.65%	16.50%	15.83%	13.05%	11.63%	13.31%
Return on Assets (ROA)	7.85%	7.49%	7.56%	6.93%	7.02%	9.11%
Return on Invested Capital (ROIC)	9.14%	9.01%	9.12%	7.98%	7.85%	10.15%
Return on Capital Employed (ROCE)	13.60%	11.60%	13.40%	12.20%	12.00%	13.80%
Earnings Yield	3.37%	4.14%	2.76%	2.10%	1.91%	2.47%
FCF Yield	0.31%	-2.42%	0.76%	-0.50%	-0.56%	0.88%
Dividend Yield	0.93%	1.39%	0.87%	0.67%	0.61%	0.79%
Payout Ratio	29.85%	26.72%	23.15%	24.81%	28.52%	22.90%
Buyback Yield / Dilution	3.69%	2.21%	-0.48%	-1.00%	-7.31%	-4.58%
Total Shareholder Return	4.61%	3.60%	0.40%	-0.33%	-6.69%	-3.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.